Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness.
Hedge Fund - Sabby Capital
News, Interviews, and Investor Letters
- First
- << Previous
- 61 - 69
Lpath, Inc. (LPTN), Oplink Communications, Inc (OPLK): Sabby Management and Engaged Capital's Latest SEC Filings
Hal Mintz's Sabby Management and Glenn W. Welling's Engaged Capital reported changes to their stakes in Lpath, Inc. (NASDAQ:LPTN) and Oplink Communications, Inc (NASDAQ:OPLK) respectively.
Aastrom Biosciences Inc (ASTM), The Providence Service Corporation (PRSC): Sabby Capital's & Coliseum Capital's Latest Moves
In two different filings with the U.S.
Hal Mintz And Sabby Capital Disclose New Investments In StemCells Inc (STEM) And Skystar Bio-Pharmaceutical Company (SKBI)
Hal Mintz, the manager of Sabby Capital, believes StemCells Inc (NASDAQ:STEM) is a good investment and has opened a position for his fund.
Sabby Capital Reveals New 7.3% Stake In RiceBran Technologies (RIBT)
RiceBran Technologies (NASDAQ:RIBT) has caught the attention of Hal Mintz, who has initiated a new position.
Hal Mintz, Sabby Management Report 7.43% Stake in Oxygen Biotherapeutics, Inc. (OXBT)
Hal Mintz' Sabby Management has reported a new stake in the biotechnology company Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), a new filing with the SEC shows.
Sabby Management Adds Bioline RX Ltd (BLRX) & Recro Pharma Inc (REPH) to Its Equity Portfolio
In a couple of new filings with the SEC, Hal Mintz's Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ:BLRX) and Recro Pharma Inc (NASDAQ:REPH).
Make That 2 Biotech Stocks Today: Sabby Management Reveals It Bought Advaxis
Sabby Management, Advaxis: Advaxis, Inc. (NASDAQ:ADXS), a micro-cap biotech development company, has just seen Hal Mintz's Sabby Management disclose a 6.3% stake.
Sabby Management Joins Alpha Capital Anstalt in DARA Biosciences With 8.3% Stake
Sabby Management, Dara Biosciences: In a new 13G filing just reported to the SEC, Hal Mintz's Sabby Management reported an 8.3% stake in DARA Biosciences Inc (NASDAQ:DARA) stock.
- First
- << Previous
- 61 - 69